نتایج جستجو برای: cord blood transplantation

تعداد نتایج: 874390  

Aysan Farhadi, Bahram Mohammad Soltani, Tahereh Foroutan,

Introduction: Human hematopoietic stem cells (hHSCs) have been used for transplantation in hematologic failures. Because the number of hHSCs per cord blood unit is limited, the expansion of these cells is important for clinical application. It has been reported that cytokines and feeder layer provide a perspective to in vitro expansion of hHSCs. In this regard, cord blood CD34+ cells ex...

Journal: :Pediatrics 2007
William T Shearer Bertram H Lubin Mitchell S Cairo Luigi D Notarangelo

This policy statement is intended to provide information to guide pediatricians, obstetricians, and other medical specialists and health care providers in responding to parents' questions about cord blood donation and banking as well as the types (public versus private) and quality of cord blood banks. Cord blood is an excellent source of stem cells for hematopoietic stem cell transplantation i...

2017
Makoto Murata Yoshinobu Maeda Masayoshi Masuko Yasushi Onishi Tomoyuki Endo Seitaro Terakura Yuichi Ishikawa Chisako Iriyama Yoko Ushijima Tatsunori Goto Nobuharu Fujii Mitsune Tanimoto Hironori Kobayashi Yasuhiko Shibasaki Noriko Fukuhara Yoshihiro Inamoto Ritsuro Suzuki Yoshihisa Kodera Tadashi Matsushita Hitoshi Kiyoi Tomoki Naoe Tetsuya Nishida

The outcomes of cord blood transplantation with non-irradiated reduced-intensity conditioning for hematological malignancies need to be improved because of graft failure and delayed engraftment. Intrabone infusion of cord blood cells has the potential to resolve the problems. In this phase II study, 21 adult patients with hematological malignancy received intrabone transplantation of serologica...

Journal: :Haematologica 2005
Akiyoshi Takami Kanako Mochizuki Hidesaku Asakura Hirohito Yamazaki Hirokazu Okumura Shinji Nakao

This retrospective analysis of cytomegalovirus (CMV)-seropositive adult transplant recipients showed that CMV antigenemia occurred after transplantation in 10/10 (100%) recipients of unrelated cord blood, 17/39 (43%) recipients of a related matched donor graft, 16/23 (79%) recipients of an unrelated matched donor graft, and 8/12 (67%) recipients of a mismatched related donor graft. These result...

Journal: :Blood 2005
Bregje Mommaas Janine A Stegehuis-Kamp Astrid G van Halteren Michel Kester Jürgen Enczmann Peter Wernet Gesine Kögler Tuna Mutis Anneke Brand Els Goulmy

Umbilical cord blood transplantation is applied as treatment for mainly pediatric patients with hematologic malignancies. The clinical results show a relatively low incidence of graft-versus-host disease and leukemia relapse. Since maternal cells traffic into the fetus during pregnancy, we questioned whether cord blood has the potential to generate cytotoxic T cells specific for the hematopoiet...

2014
Faezeh Tajalli Reza Eftekhari Vakili

Nowadays, the use of umbilical cord blood (UCB) stem cells is promoting for related and unrelated donor transplantation. A successful transplant happens when quality of isolated cells will be high. Therefore, in addition to yield of quantitative production, to provide safe and effective products is very important in cord blood banks, because these products have to create the conditions and resu...

2013
Wan-Zhang Yang Guo-Jian Shu Yun Zhang Fang Wu Bi-Yu Ye Xiang Hu

INTRODUCTION Herpes simplex virus is the most common cause of sporadic viral encephalitis. Cognitive impairments persist in most patients who survive herpes simplex virus-caused encephalitis after undergoing currently available treatments. This is the first report on the development of human cord blood-derived mononuclear cell transplantation as a new treatment intervention to improve the progn...

Journal: :Pediatrics 2007
Ammar Hayani Eberhard Lampeter David Viswanatha David Morgan Sharad N Salvi

We present the case of a 3-year-old girl with acute lymphoblastic leukemia who developed isolated central nervous system relapse while receiving chemotherapy 10 months after diagnosis. The child achieved a second remission on retreatment with systemic and intrathecal chemotherapy. She then underwent myeloablative chemotherapy and radiation therapy followed by infusion of her own umbilical cord ...

Journal: :Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 2007
Kenji Tajika Taro Mizuki Kazutaka Nakayama Hiroki Yamaguchi Kazuo Dan

Immunosuppressive therapy and stem cell transplantation from an HLA-identical donor are the major effective treatments for severe aplastic anemia. However, treatments still need to be developed for patients who do not have a HLA-identical donor and have not shown a clinical response to immunosuppressive therapy. We herein report on 2 patients in whom this problem could be overcome by transplant...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید